JP2025504363A5 - - Google Patents
Info
- Publication number
- JP2025504363A5 JP2025504363A5 JP2024540715A JP2024540715A JP2025504363A5 JP 2025504363 A5 JP2025504363 A5 JP 2025504363A5 JP 2024540715 A JP2024540715 A JP 2024540715A JP 2024540715 A JP2024540715 A JP 2024540715A JP 2025504363 A5 JP2025504363 A5 JP 2025504363A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cancer
- amino acid
- acid sequence
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263296774P | 2022-01-05 | 2022-01-05 | |
| US63/296,774 | 2022-01-05 | ||
| US202263417926P | 2022-10-20 | 2022-10-20 | |
| US63/417,926 | 2022-10-20 | ||
| PCT/US2023/060074 WO2023133394A1 (en) | 2022-01-05 | 2023-01-04 | Gamma delta t-cell-binding polypeptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504363A JP2025504363A (ja) | 2025-02-12 |
| JP2025504363A5 true JP2025504363A5 (enExample) | 2025-12-26 |
Family
ID=85199216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540715A Pending JP2025504363A (ja) | 2022-01-05 | 2023-01-04 | γδＴ細胞結合ポリペプチド及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250066477A1 (enExample) |
| EP (1) | EP4460521A1 (enExample) |
| JP (1) | JP2025504363A (enExample) |
| KR (1) | KR20240130130A (enExample) |
| CN (1) | CN119213028A (enExample) |
| AU (1) | AU2023205911A1 (enExample) |
| CA (1) | CA3242658A1 (enExample) |
| IL (1) | IL314073A (enExample) |
| MX (1) | MX2024008389A (enExample) |
| TW (1) | TW202334233A (enExample) |
| WO (1) | WO2023133394A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025140683A1 (zh) * | 2023-12-29 | 2025-07-03 | 北京鼎成肽源生物技术有限公司 | 表达趋化因子10和白介素15的工程化免疫细胞 |
| WO2025144974A1 (en) * | 2023-12-29 | 2025-07-03 | Absci Corporation | Half-life extending fc domain variants and uses thereof |
| WO2026006719A1 (en) * | 2024-06-28 | 2026-01-02 | IN8bio, Inc. | Multifunctional molecules and methods of treatment |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| DK1034298T3 (da) | 1997-12-05 | 2012-01-30 | Scripps Research Inst | Humanisering af murint antistof |
| US7217797B2 (en) | 2002-10-15 | 2007-05-15 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| CA2541651C (en) | 2003-10-22 | 2011-05-24 | Keck Graduate Institute | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| EP1740615B1 (en) | 2004-03-31 | 2014-11-05 | Genentech, Inc. | Humanized anti-tgf-beta antibodies |
| DK3129404T3 (da) * | 2014-04-10 | 2026-04-20 | Lava Therapeutics N V | Immunglobuliner, der binder humane vgamma9vdelta2-t-cellereceptorer |
| GB201707048D0 (en) * | 2017-05-03 | 2017-06-14 | King S College London | Expansion of gamma delta cells, compositions, and methods of use thereof |
| JP7611820B2 (ja) * | 2018-10-11 | 2025-01-10 | インヒブルクス バイオサイエンシズ インコーポレイテッド | Ｄｌｌ３シングルドメイン抗体およびその治療用組成物 |
| CN113993893A (zh) * | 2019-02-01 | 2022-01-28 | 拉法医疗有限公司 | 新cd40结合抗体 |
| BR112021020999A2 (pt) * | 2019-05-04 | 2021-12-14 | Inhibrx Inc | Polipeptídeos de ligação à clec12a e usos dos mesmos |
| MX2022006547A (es) * | 2019-12-03 | 2022-08-19 | Adicet Bio Inc | Métodos para la expansión de poblaciones de células t gamma delta con agentes multivalentes y composiciones de estas. |
| CN115485369A (zh) * | 2020-03-03 | 2022-12-16 | 詹森生物科技公司 | γδT细胞及其用途 |
-
2023
- 2023-01-04 JP JP2024540715A patent/JP2025504363A/ja active Pending
- 2023-01-04 US US18/726,347 patent/US20250066477A1/en active Pending
- 2023-01-04 TW TW112100154A patent/TW202334233A/zh unknown
- 2023-01-04 CN CN202380016082.6A patent/CN119213028A/zh active Pending
- 2023-01-04 IL IL314073A patent/IL314073A/en unknown
- 2023-01-04 WO PCT/US2023/060074 patent/WO2023133394A1/en not_active Ceased
- 2023-01-04 AU AU2023205911A patent/AU2023205911A1/en active Pending
- 2023-01-04 EP EP23704000.1A patent/EP4460521A1/en active Pending
- 2023-01-04 KR KR1020247026008A patent/KR20240130130A/ko active Pending
- 2023-01-04 CA CA3242658A patent/CA3242658A1/en active Pending
-
2024
- 2024-07-02 MX MX2024008389A patent/MX2024008389A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023513003A5 (enExample) | ||
| JP2024526835A5 (enExample) | ||
| JP2024534838A5 (enExample) | ||
| JP2025504363A5 (enExample) | ||
| JP2020536549A5 (enExample) | ||
| JP2022116230A5 (enExample) | ||
| JP2022516557A5 (enExample) | ||
| Nie et al. | Biology drives the discovery of bispecific antibodies as innovative therapeutics | |
| JP2019513347A5 (enExample) | ||
| TWI828625B (zh) | 引導及導航控制蛋白質以及彼之製造及使用方法 | |
| US20210008113A1 (en) | Methods of making and using guidance and navigation control proteins | |
| JP2023532904A5 (enExample) | ||
| RU2020142965A (ru) | Иммуноглобулин с тандемным расположением fab-фрагментов и его применение | |
| RU2018106452A (ru) | Поливалетные и полиспецифичные gitr-связывающие слитые белки | |
| JP2017513818A5 (enExample) | ||
| RU2018128462A (ru) | Модифицированные клетки для иммунотерапии | |
| CN104592392B (zh) | 一种双特异性抗体EpCAM×CD3的构建及应用 | |
| HRP20191800T1 (hr) | Polipeptidi koji regrutiraju t stanice koji se temelje na tcr alfa/beta reaktivnosti | |
| JP2019503200A (ja) | 癌の治療のための組成物及び方法 | |
| JP2017506215A5 (enExample) | ||
| HRP20190756T1 (hr) | Cd3-vezujuće molekule sposobne za vezanje za humani i nehumani cd3 | |
| CN108250302A (zh) | 一种多功能蛋白质 | |
| JP2024546999A5 (enExample) | ||
| JP2024534471A5 (enExample) | ||
| JP2021534784A5 (enExample) |